These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 19414792

  • 1. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.
    Orth D, Khan AB, Naim A, Grif K, Brockmeyer J, Karch H, Joannidis M, Clark SJ, Day AJ, Fidanzi S, Stoiber H, Dierich MP, Zimmerhackl LB, Würzner R.
    J Immunol; 2009 May 15; 182(10):6394-400. PubMed ID: 19414792
    [Abstract] [Full Text] [Related]

  • 2. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
    Poolpol K, Orth-Höller D, Speth C, Zipfel PF, Skerka C, de Córdoba SR, Brockmeyer J, Bielaszewska M, Würzner R.
    Mol Immunol; 2014 Mar 15; 58(1):77-84. PubMed ID: 24317278
    [Abstract] [Full Text] [Related]

  • 3. Complement in typical hemolytic uremic syndrome.
    Orth D, Würzner R.
    Semin Thromb Hemost; 2010 Sep 15; 36(6):620-4. PubMed ID: 20865638
    [Abstract] [Full Text] [Related]

  • 4. Role of complement in enterohemorrhagic Escherichia coli-Induced hemolytic uremic syndrome.
    Orth-Höller D, Würzner R.
    Semin Thromb Hemost; 2014 Jun 15; 40(4):503-7. PubMed ID: 24799304
    [Abstract] [Full Text] [Related]

  • 5. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
    Prado V, Cordero J, Garreaud C, Olguin H, Arellano C, Nachar CL, Misraji A, Martínez J, Tous M, Rivas M.
    Rev Med Chil; 1995 Jan 15; 123(1):13-22. PubMed ID: 7569441
    [Abstract] [Full Text] [Related]

  • 6. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
    Karch H.
    Semin Thromb Hemost; 2001 Jun 15; 27(3):207-13. PubMed ID: 11446654
    [Abstract] [Full Text] [Related]

  • 7. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
    Allerberger F, Sölder B, Caprioli A, Karch H.
    Wien Klin Wochenschr; 1997 Sep 19; 109(17):669-77. PubMed ID: 9381722
    [Abstract] [Full Text] [Related]

  • 8. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C.
    J Immunol; 2011 Jul 01; 187(1):172-80. PubMed ID: 21642543
    [Abstract] [Full Text] [Related]

  • 9. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
    Ibarra C, Goldstein J, Silberstein C, Zotta E, Belardo M, Repetto HA.
    Arch Argent Pediatr; 2008 Oct 01; 106(5):435-42. PubMed ID: 19030644
    [Abstract] [Full Text] [Related]

  • 10. Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans.
    Orth D, Grif K, Zimmerhackl LB, Würzner R.
    Expert Rev Anti Infect Ther; 2008 Feb 01; 6(1):101-8. PubMed ID: 18251667
    [Abstract] [Full Text] [Related]

  • 11. Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.
    Ehrlenbach S, Rosales A, Posch W, Wilflingseder D, Hermann M, Brockmeyer J, Karch H, Satchell SC, Würzner R, Orth-Höller D.
    Infect Immun; 2013 Aug 01; 81(8):2678-85. PubMed ID: 23690395
    [Abstract] [Full Text] [Related]

  • 12. Treatment of typical (enteropathic) hemolytic uremic syndrome.
    Bitzan M, Schaefer F, Reymond D.
    Semin Thromb Hemost; 2010 Sep 01; 36(6):594-610. PubMed ID: 20865636
    [Abstract] [Full Text] [Related]

  • 13. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome.
    Tazzari PL, Ricci F, Carnicelli D, Caprioli A, Tozzi AE, Rizzoni G, Conte R, Brigotti M.
    Cytometry B Clin Cytom; 2004 Sep 01; 61(1):40-4. PubMed ID: 15351981
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology and pathogenesis of enterohaemorrhagic Escherichia coil.
    Karch H, Mellmann A, Bielaszewska M.
    Berl Munch Tierarztl Wochenschr; 2009 Sep 01; 122(11-12):417-24. PubMed ID: 19999376
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
    Yamada S, Shimizu M, Kuroda M, Inoue N, Sugimoto N, Yachie A.
    Clin Exp Nephrol; 2019 Apr 01; 23(4):544-550. PubMed ID: 30467800
    [Abstract] [Full Text] [Related]

  • 16. Enterohaemorrhagic Escherichia coli O26:H11/H-: a human pathogen in emergence.
    Bielaszewska M, Zhang W, Mellmann A, Karch H.
    Berl Munch Tierarztl Wochenschr; 2007 Apr 01; 120(7-8):279-87. PubMed ID: 17715820
    [Abstract] [Full Text] [Related]

  • 17. [Hemolytic uremic syndrome].
    Rota S, Cravedi P, Remuzzi G, Ruggenenti P.
    G Ital Nefrol; 2005 Apr 01; 22 Suppl 33():S57-64. PubMed ID: 16419008
    [Abstract] [Full Text] [Related]

  • 18. [Hemolytic and uremic syndrome and maternal-fetal Escherichia coli K1 infection].
    Flandrois M, Bessière A, Vieira-Roth S, Vergnaud M, Frémeaux-Bacchi V, Eckart P.
    Arch Pediatr; 2011 Mar 01; 18(3):283-6. PubMed ID: 21269814
    [Abstract] [Full Text] [Related]

  • 19. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
    Arvidsson I, Ståhl AL, Hedström MM, Kristoffersson AC, Rylander C, Westman JS, Storry JR, Olsson ML, Karpman D.
    J Immunol; 2015 Mar 01; 194(5):2309-18. PubMed ID: 25637016
    [Abstract] [Full Text] [Related]

  • 20. Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli.
    Kamitsuji H, Nonami K, Murakami T, Ishikawa N, Nakayama A, Umeki Y.
    Clin Nephrol; 2000 May 01; 53(5):319-24. PubMed ID: 11305804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.